Abstract

Physiochemical Compatibility of Nebulizable Drug Admixtures Containing Budesonide and Colistmethate or Hypertonic Saline

Author(s): Klemmer Anja, Krämer Irene, Kamin Wolfgang

Issue: May/Jun 2013 - Volume 17, Number 3

Page(s): 254-261

Download in electronic PDF format for $75
  • Physiochemical Compatibility of Nebulizable Drug Admixtures Containing Budesonide and Colistmethate or Hypertonic Saline Page 1
  • Physiochemical Compatibility of Nebulizable Drug Admixtures Containing Budesonide and Colistmethate or Hypertonic Saline Page 2
  • Physiochemical Compatibility of Nebulizable Drug Admixtures Containing Budesonide and Colistmethate or Hypertonic Saline Page 3
  • Physiochemical Compatibility of Nebulizable Drug Admixtures Containing Budesonide and Colistmethate or Hypertonic Saline Page 4
  • Physiochemical Compatibility of Nebulizable Drug Admixtures Containing Budesonide and Colistmethate or Hypertonic Saline Page 5
  • Physiochemical Compatibility of Nebulizable Drug Admixtures Containing Budesonide and Colistmethate or Hypertonic Saline Page 6
  • Physiochemical Compatibility of Nebulizable Drug Admixtures Containing Budesonide and Colistmethate or Hypertonic Saline Page 7
  • Physiochemical Compatibility of Nebulizable Drug Admixtures Containing Budesonide and Colistmethate or Hypertonic Saline Page 8

Abstract

Knowledge of the physicochemical compatibility of admixtures of nebulizable drugs is an important issue. In this article, the results of our recent study dealing with the compatibility of drug admixtures containing budesonide and colistin methanesulfonate (brand name Colistin CF) or budesonide and 5.85% sodium chloride solution are presented, as well as the up-to-date version of our compatibility table. Admixtures were prepared by mixing 2.0 mL Pulmicort either with 3.0 mL Colistin CF or 4.0 mL 5.85% sodium chloride solution. Test solutions were stored for 24 hours at room temperature under ambient light conditions. Physical compatibility was determined by measuring pH and osmolality. Concentrations of budesonide were measured by a high-performance liquid chromatography assay. The antibiotic activity of colistin methanesulfonate was determined in comparison to standard solutions using a microbiological assay. No loss in drug concentration of budesonide and no change in antibiotic activity of colistin methanesulfonate were detected over a test period of 24 hours. Osmolality remained unchanged in both types of admixtures. In admixtures of budesonide with colistin methanesulfonate, pH increased during the first 4 hours of storage, while in admixtures of budesonide and hypertonic saline pH remained unchanged. No visible changes could be detected. Due to these results admixtures of budesonide and colistin methanesulfonate or 5.85% sodium chloride solution are designated to be compatible, but it is recommended that mixing should take place immediately before administration. Further investigations are needed to determine whether or not drug delivery is affected by mixing the drugs and to ensure simultaneous nebulization is recommendable.

Related Keywords

  • drug admixtures
  • nebulizable agents
  • aerosolized medications
  • inhalation solutions
  • inhalation suspensions
  • inhalation therapy
  • physicochemical compatibility
  • drug stability
  • budesonide
  • glucocorticoid
  • corticosteroid
  • inhaled steroid
  • colistin methanesulfonate
  • anti-inflammatory agent
  • polymixin antibiotic
  • antimicrobial agent
  • antibacterial agent
  • airway infection
  • bronchoconstriction
  • cough
  • airway inflammation
  • bronchodilator
  • osmolality
  • pH
  • drug delivery

Related Categories

  • PEER-REVIEWED
  • STABILITIES, COMPATIBILITIES
  • DOSAGE FORMS/DRUG CARRIERS
  • RESPIRATION/LUNG/BREATHING

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
May/Jun 2013
Pg. 254-261
Physiochemical Compatibility of Nebulizable Drug Admixtures Containing Budesonide and Colistmethate or Hypertonic Saline
Author(s): Klemmer Anja, Krämer Irene, Kamin Wolfgang
May/Jun 2020
Pg. 242-245
Physicochemical Stability and Compatibility of Revefenacin (LAMA) and Formoterol Fumarate (LABA) Inhalation Solution Admixture
Author(s): Ngim Kenley, Patel Jalpa
Mar/Apr 2003
Pg. 106-113
Veterinary Transdermal Medications: A to Z
Author(s): Davidson Gigi S
Sep/Oct 2007
Pg. 426-432
Zinc Content of Commercial Diluents Widely Use in Drug Admixtures Prepared for Intravenous Infusion
Author(s): Desai Narendra R, Shah Syed M, Koczone Julianna, Vencl-Joncic Maja, Sisto Christopher, Ludwig Stephen A
May/Jun 2011
Pg. 190-192
Drug Compatibility and Stability in Dextrose vs Saline
Author(s): Newton David W
May/Jun 2021
Pg. 222-229
Intravenous Admixture Preparation Considerations, Part 9-B: Error Prevention in Intravenous Admixture Preparation
Author(s): Allen Loyd V Jr
Mar/Apr 2021
Pg. 131-139
Intravenous Admixture Preparation Considerations, Part 9-A: Error Prevention in Intravenous Admixture Preparation
Author(s): Allen Loyd V Jr
Jan/Feb 2020
Pg. 44-50
Intravenous Admixture Preparation Considerations, Part 2: Incompatibilities and Factors Involved
Author(s): Allen Loyd V Jr
Sep/Oct 2017
Pg. 408
Acetylcysteine Solutions for Inhalation
Author(s): Allen Loyd V Jr
Jul/Aug 2016
Pg. 328-332
Y-site Physical Compatibility of Beta-blocker Infusions with Intensive Care Unit Admixtures
Author(s): Foushee Jaime A, Meredith Pmichaele, Fox Laura M, Grace EdwardE
Nov/Dec 2016
Pg. 521-525
Stability of Ribavirin for Inhalation Packaged in Syringes or Glass Vials when Stored Frozen, Refrigerated, and at Room Temperature
Author(s): Larson Bayli, Bushman Lane R, Casciano Matthew L, Oldland Alan R, Kiser Jennifer J, Kiser Tyree H
Nov/Dec 2019
Pg. 478-482
Intravenous Admixture Preparation Considerations, Part 1: Overview of Series on Personnel Selection for Intravenous Admixture Compounding
Author(s): Allen Loyd V Jr
Nov/Dec 2025
Pg. 489-490
Albuterol Sulfate 1 mg/mL and Ipratropium Bromide 0.2 mg/mL Sterile Inhalation Solution, Preservative -Free
Author(s):
Mar/Apr 2003
Pg. 133
Albuterol Sulfate 0.5% Inhalation Solution
Author(s): Allen Loyd V Jr
Nov/Dec 2000
Pg. 455
Flunisolide 0.025% Inhalation Solution (Preservative Free)
Author(s): Allen Loyd V Jr
Nov/Dec 2002
Pg. 415-417
Sterile Compounding of Respiratory Inhalation Solutions
Author(s): Roberts Rob, Moore Eddie
Jan/Feb 2000
Pg. 58
Morphine Sulfate 2.5-mg/mL Inhalation Solution
Author(s): Allen Loyd V Jr
Jul/Aug 1997
Pg. 259
Kennel Cough Inhalation Solutions (Concentrated)
Author(s): Allen Loyd V Jr
Jul/Aug 2001
Pg. 310-312
Wetting and/or Solubilizing Agents, Featured Excipient:
Author(s): Allen Loyd V Jr
Mar/Apr 1997
Pg. 121-122
The Compatibility of Common Respiratory Therapy Drug Combinations
Author(s): Owsley Heather D, Rusho William F